The first mouse model of CMT2D was established in 2006 after identification of the dominant Nmf249 Gars1 mutation (P278KY; equivalent to human P234KY) in a forward genetic screen (Seburn et al., 2006). Here, GARS1 is linked to Charcot-Marie-Tooth disease type 2D.